Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations
Key facts
- Who runs it
- The Eye institute of Utah
- Where
- Salt Lake City, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 9 Jan 2025
- Planned end
- 22 Feb 2025
- Type of study
- Observational
- Record updated
- 30 January 2025
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- 21 years or older (Adult age)
- Assessed to have Cataract Grade 1 and above per LOCS III or Wisconsin Grading scale in at least one eye
- Able to comprehend and sign the informed consent form
- Potential postoperative best corrected distance visual acuity (BCDVA) of 0.3 logMAR or better and targeted post-op refraction to be emmetropia, based on the investigator expert medical opinion
Who cannot take part
- No active ocular infection or inflammation
- Contraindicated for pupil dilation (e.g., narrow angles, allergies) per medical judgement of the investigator
- Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study
- Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Cataract
This trial is currently available in United States.
- The Eye Institute of UtahSalt Lake City, United StatesContact: Lexi GuildTaking people
About the trial
What the trial wants to find out
The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoing cataract surgery.
The group in the trial
- Observational
No interventions will be administered.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06801678, who can take part
- Record updated
- 30 January 2025